The Biosafety Research Road Map: The Search for Evidence to Support Practices in Human and Veterinary Laboratories

Blacksell, Stuart D.; Dhawan, Sandhya; Kusumoto, Marina; Le, Kim Khanh; Summermatter, Kathrin; O'Keefe, Joseph; Kozlovac, Joseph; Almuhairi, Salama Suhail; Sendow, Indrawati; Scheel, Christina M.; Ahumibe, Anthony; Masuku, Zibusiso M.; Bennett, Allan M.; Kojima, Kazunobu; Harper, David R.; Hamilton, Keith (2023). The Biosafety Research Road Map: The Search for Evidence to Support Practices in Human and Veterinary Laboratories. Applied biosafety, 28(2), pp. 64-71. Mary Ann Liebert 10.1089/apb.2022.0040

Preview

Text apb.2022.0040.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (197kB) | Preview

Introduction: Lack of evidence-based information regarding potential biological risks can result in inappropriate or excessive biosafety and biosecurity risk-reduction strategies. This can cause unnecessary damage and loss to the physical facilities, physical and psychological well-being of laboratory staff, and community trust. A technical working group from the World Organization for Animal Health (WOAH, formerly OIE), World Health Organization (WHO), and Chatham House collaborated on the Biosafety Research Roadmap (BRM) project. The goal of the BRM is the sustainable implementation of evidence-based biorisk management of laboratory activities, particularly in low-resource settings, and the identification of gaps in the current biosafety and biosecurity knowledge base.

Methods: A literature search was conducted for the basis of laboratory design and practices for four selected high-priority subgroups of pathogenic agents. Potential gaps in biosafety were focused on five main sections, including the route of inoculation/modes of transmission, infectious dose, laboratory-acquired infections, containment releases, and disinfection and decontamination strategies. Categories representing miscellaneous, respiratory, bioterrorism/zoonotic, and viral hemorrhagic fever pathogens were created within each group were selected for review.

Results: Information sheets on the pathogens were developed. Critical gaps in the evidence base for safe sustainable biorisk management were identified.

Conclusion: The gap analysis identified areas of applied biosafety research required to support the safety, and the sustainability, of global research programs. Improving the data available for biorisk management decisions for research with high-priority pathogens will contribute significantly to the improvement and development of appropriate and necessary biosafety, biocontainment and biosecurity strategies for each agent.

Interest & Impact

Downloads

97 since deposited on 14 Jun 2023
93 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item